Accelerate Brain Cancer Cure will hold its tenth annual Scientific Retreat from September 28-30th in Sausalito, California. Leaders on the frontier of cancer research, along with top funders, convene to share promising translational research developments, foster collaboration and identify new opportunities for the coming year.
The retreat will be attended by preeminent scientists and clinicians, as well as patients, industry and government officials representing more than 25 institutions, including: UCLA, Genentech, Duke University, Amgen, Fred Hutchinson Cancer Research Center, Google, UCSD, Tocagen, The Chordoma Foundation, Harvard/Dana Farber, UCSF, The National Brain Tumor Society, Johns Hopkins, MD Anderson Cancer Center, Novartis, The V Foundation, Quintiles Innovation, Agios, The Ludwig Institute for Cancer Research and others.
The presentations will focus on innovations in translational research, including: multiple genetic pathways that lead to brain cancer, therapeutic potential of targeting the IDH1 gene, and immune therapy approaches to battling the disease.
Click here for the 2011 Annual Scientific Retreat agenda.
